Crispr Therapeutics AG (CRSP)
NASDAQ · Healthcare
Crispr Therapeutics AG Revenue 2015–2025
Crispr Therapeutics AG annual/quarterly revenue history and growth rate from 2015 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Crispr Therapeutics AG revenue for the quarter ending March 31, 2026 was 1.5 M, a 68.55% increase year-over-year.
- Crispr Therapeutics AG revenue for the twelve months ending March 31, 2026 was 4.1 M, a 152.87% increase year-over-year.
- Crispr Therapeutics AG annual revenue for 2025 was 3.5 M, a 90.59% decrease from 2024.
- Crispr Therapeutics AG annual revenue for 2024 was 37.3 M, a 89.95% decrease from 2023.
- Crispr Therapeutics AG annual revenue for 2023 was 371.2 M, a 30885.48% increase from 2022.
- Crispr Therapeutics AG annual revenue for 2022 was 1.2 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Crispr Therapeutics AG Market Cap — FAQ
Crispr Therapeutics AG (CRSP) market cap over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CRSP's market cap history?
The chart and table above show Crispr Therapeutics AG's market cap by year and by quarter, including the growth rate.